433 related articles for article (PubMed ID: 19041064)
1. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease.
Kim DH; Lee NY; Lee MH; Sohn SK
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1408-16. PubMed ID: 19041064
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
Kim DH; Lee NY; Lee MH; Sohn SK; Do YR; Park JY
Br J Haematol; 2008 Jan; 140(1):71-9. PubMed ID: 17983459
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
Kim DH; Jung HD; Lee NY; Sohn SK
Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
Min CK; Kim SY; Lee MJ; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Cho CS
Bone Marrow Transplant; 2006 Jul; 38(2):149-56. PubMed ID: 16751784
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
[TBL] [Abstract][Full Text] [Related]
7. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
[TBL] [Abstract][Full Text] [Related]
8. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation.
Mlynarczewska A; Wysoczanska B; Karabon L; Bogunia-Kubik K; Lange A
Bone Marrow Transplant; 2004 Aug; 34(4):339-44. PubMed ID: 15235581
[TBL] [Abstract][Full Text] [Related]
9. High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.
Cho BS; Min CK; Kim HJ; Lee S; Kim YJ; Lim JY; Jeong DC; Cho B; Kim HK; Eom KS; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Chung NG
Biol Blood Marrow Transplant; 2010 May; 16(5):629-38. PubMed ID: 19963070
[TBL] [Abstract][Full Text] [Related]
10. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
[TBL] [Abstract][Full Text] [Related]
11. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
Seo KW; Kim DH; Sohn SK; Lee NY; Chang HH; Kim SW; Jeon SB; Baek JH; Kim JG; Suh JS; Lee KB
Bone Marrow Transplant; 2005 Dec; 36(12):1089-95. PubMed ID: 16247433
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
[TBL] [Abstract][Full Text] [Related]
13. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
[TBL] [Abstract][Full Text] [Related]
17. Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation.
Ambruzova Z; Mrazek F; Raida L; Stahelova A; Faber E; Indrak K; Petrek M
Hum Immunol; 2009 Jun; 70(6):457-60. PubMed ID: 19286444
[TBL] [Abstract][Full Text] [Related]
18. The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease.
Al-Habboubi HH; Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Almawi WY
Eur J Haematol; 2012 Nov; 89(5):403-9. PubMed ID: 22925497
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
